Stimulation of granulocyte functions in vitro by imipenem and the renal enzyme inhibitor MK 0791.

Por Gnarpe, H, Belsheim, J, Blomqvist, C, Lundbäck, A
Publicado em 1984

Lead specificity of the maximum ST/heart rate slope response.

Por Beattie, J M, Seibert, G B, Blomqvist, C G
Publicado em 1985

Measurement of growth rate of lung metastases in 21 patients with bone or soft-tissue sarcoma.

Por Blomqvist, C., Wiklund, T., Tarkkanen, M., Elomaa, I., Virolainen, M.
Publicado em 1993

Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer.

Por Saarto, T., Blomqvist, C., Rissanen, P., Auvinen, A., Elomaa, I.
Publicado em 1997

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF

Por Poikonen, P, Saarto, T, Lundin, J, Joensuu, H, Blomqvist, C
Publicado em 1999

Exercise testing in men with significant left main coronary disease.

Por Nixon, J V, Lipscomb, K, Blomqvist, C G, Shapiro, W
Publicado em 1979

Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast...

Por Saarto, T., Blomqvist, C., Risteli, J., Risteli, L., Sarna, S., Elomaa, I.
Publicado em 1998

Clodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens.

Por Saarto, T., Blomqvist, C., Välimäki, M., Mäkelä, P., Sarna, S., Elomaa, I.
Publicado em 1997

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

Por Vahteristo, P, Eerola, H, Tamminen, A, Blomqvist, C, Nevanlinna, H
Publicado em 2001

Tamoxifen treatment reverses the adverse effects of chemotherapy-induced ovarian failure on serum lipids

Por Vehmanen, L, Saarto, T, Blomqvist, C, Taskinen, M-R, Elomaa, I
Publicado em 2004

Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke

Por Nilsson, G, Holmberg, L, Garmo, H, Terent, A, Blomqvist, C
Publicado em 2009

Type III collagen metabolism in soft tissue sarcomas.

Por Wiklund, T. A., Elomaa, I., Blomqvist, C. P., Risteli, L., Risteli, J.
Publicado em 1992

Type I and type III collagen metabolites in adult osteosarcoma patients.

Por Wiklund, T., Blomqvist, C., Risteli, L., Risteli, J., Karaharju, E., Elomaa, I.
Publicado em 1996

Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma.

Por Blomqvist, C., Risteli, L., Risteli, J., Virkkunen, P., Sarna, S., Elomaa, I.
Publicado em 1996

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer.

Por Niskanen, E., Blomqvist, C., Franssila, K., Hietanen, P., Wasenius, V. M.
Publicado em 1997

The effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancer

Por Saarto, T, Vehmanen, L, Elomaa, I, Välimäki, M, Mäkelä, P, Blomqvist, C
Publicado em 2001

Incidence of arrhythmias induced by isometric and dynamic exercise.

Por Atkins, J M, Matthews, O A, Blomqvist, C G, Mullins, C B
Publicado em 1976

Do DNA ploidy and S-phase fraction in primary tumour predict the response to chemotherapy in metastatic breast cancer?

Por Hietanen, P., Blomqvist, C., Wasenius, V. M., Niskanen, E., Franssila, K., Nordling, S.
Publicado em 1995

Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to te...

Por Jahkola, T, Toivonen, T, Smitten, K von, Virtanen, I, Wasenius, V-M, Blomqvist, C
Publicado em 1999

The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised...

Por Blomqvist, C., Tiusanen, K., Elomaa, I., Rissanen, P., Hietanen, T., Heinonen, E., Gröhn, P.
Publicado em 1992